First Glyphosate Roundup Trial Ends in Major Victory for Dying Plaintiff: Monsanto Ordered to Pay $289 Million
On Friday, after two and a half days of deliberation, the jury in the case Dewayne Johnson v. Monsanto Company, et. al. determined the plaintiff's terminal cancer was caused partially by exposure to glyphosate, the active ingredient in the herbicide Roundup.
The first glyphosate lawsuit against agribusiness giant Monsanto got underway last week in a federal court in San Francisco. This week, the plaintiff, 46-year-old Dewayne Johnson, took the stand to give a first-hand account of how glyphosate exposure has literally destroyed his life.
The “marriage made in hell” that farmers, environmental activists, and consumers have been dreading is scheduled to be consummated this week. Despite serious massive protests, the U.S. Department of Justice announced last week that it would approve the merger on the condition that Bayer divest itself of its BASF division, which represents approximately $9 billion in assets.
Ignoring its own guidelines for the assessment of cancer risks, the EPA has rejected evidence indicating that glyphosate, the active ingredient in Monsanto's controversial herbicide Roundup®, is carcinogenic.
Increasingly, society is coming to the inescapable conclusion that issues pertaining to race, economic justice, health, and the environment are inextricably linked. This is illustrated in a report from the Center for Biological Diversity, which found that over half of glyphosate-containing herbicides used in California are sprayed in the state's eight poorest counties. Furthermore, the majority of the people (53%) who live and work in these counties are Hispanic.
Two non-profit watchdog organizations – Beyond Pesticides and the Organic Consumers Association – filed a lawsuit against agribusiness giant Monsanto last month, alleging that the company has deliberately placed misleading and false information on the packaging of its flagship product, Roundup. The plaintiffs are demanding a trial before a jury.
The Monsanto Empire Strikes Back: Defending Glyphosate in the Face of Evidence of its Carcinogenicity
In 2015, the International Agency for Research on Cancer released its findings indicating that glyphosate, the active chemical ingredient in Monsanto's herbicide, Roundup, was “a likely carcinogen.” Since then, Monsanto, in a battle to protect its considerable profits as well as control over the world's seeds, has launched an all-out war aimed at discrediting those findings.
Forty plaintiffs recently filed a lawsuit against agribusiness giant Monsanto in California, alleging that exposure to the herbicide Roundup was the cause of their illness – specifically, non-Hodgkin lymphoma, a form of blood cancer that attacks the lymphatic system. Furthermore, plaintiffs allege that Monsanto has been falsifying data and attempting to discredit legitimate research into the health effects of Roundup's active ingredient, glyphosate.
Once again, a federal regulatory agency charged with the task of protecting consumers and the public has caved in to the demands of industry lobbyists. Just before the Environmental Protection Agency was scheduled to hold meetings of its Scientific Advisory Panel to discuss the carcinogenicity of glyphosate (the active ingredient in the controversial herbicide Roundup), CropLife America (CLA) raised objections over the presence of two scientists at the meeting.
Less than two weeks ago, The Ring of Fire reported that the FDA would finally be testing a wide range of food products for the presence of glyphosate, the active ingredient in the Monsanto herbicide Roundup. It didn't take long to find glysophate residues in a number of different baby foods. Specifically, elevated levels (up to 1.67 parts per million) of glysophate have been discovered in commercial oat meal products intended for infants.